Conclusion Prescriptive peptide therapies, including oral BPC-157, larazotide, KPV, and injectable thymosin beta-4, offer a groundbreaking approach to managing chronic conditions like leaky gut syndrome, IBD, celiac recovery, autoimmune diseases, and MCAS
Efficacy is unaffected once the peptide reaches the bloodstream it sits in the bodys own roughly 150 mM saline regardless of what you mixed it with. NAD+ is different: its pain is acidity, not mast cells reconstituted NAD+ sits near pH 3.5
Dosing & Reconstitution Guide Educational guide for reconstitution and daily dosing Standard / Gradual Approach (3 mL = ~3.33 mg/mL) Route: Subcutaneous injection, once daily [5] [6]
The same dosing protocols apply to women and men
These conditions may require a multidisciplinary approach for management, involving healthcare providers from various specialties